Trials / Recruiting
RecruitingNCT07143110
LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 60,000 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 130 Years
- Healthy volunteers
- Not accepted
Summary
LUNG-ROLL is a retrospective cohort study that will describe the contemporary treatment patterns, prevalence and incidence, patient demographic and clinical characteristics, clinical outcomes, and healthcare resource use/costs for patients with lung cancer in Canada (specifically, Alberta and Ontario) using administrative data.
Conditions
Timeline
- Start date
- 2025-08-20
- Primary completion
- 2027-09-30
- Completion
- 2027-09-30
- First posted
- 2025-08-27
- Last updated
- 2026-03-02
Locations
2 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT07143110. Inclusion in this directory is not an endorsement.